NCT07527871

Brief Summary

The purpose of this research study is to learn if an emergency department screening and telehealth intervention reduces substance use among individuals receiving emergency department treatment at The Ohio State University Wexner Medical Center.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
650

participants targeted

Target at P75+ for not_applicable

Timeline
41mo left

Started May 2026

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Sep 2029

First Submitted

Initial submission to the registry

April 7, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 14, 2026

Completed
17 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2029

Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

3.3 years

First QC Date

April 7, 2026

Last Update Submit

April 7, 2026

Conditions

Keywords

substance use

Outcome Measures

Primary Outcomes (1)

  • Self-reported substance use

    Self-reported substance use frequency

    From baseline to the sixth month follow-up assessment

Secondary Outcomes (5)

  • Self-reported substance use quantity

    From baseline to the six month follow-up

  • Incidence of positive substance use disorder screen

    From baseline to the six month follow-up

  • Toxicology assays for substance use

    From baseline to the six month follow-up assessment

  • Self-reported healthcare utilization

    Baseline to the six month follow-up assessment

  • Fatal and non-fatal overdose

    Baseline to the six month follow-up assessment

Study Arms (2)

ED-SMART intervention

EXPERIMENTAL

The ED-SMART intervention includes: (i) a brief (approximately 15 minutes) counseling session in the emergency department and (ii) five, monthly brief counseling sessions (approximately 15 to 30 minutes) delivered by telehealth. These sessions will focus on creating individualized strategies to help participants reach their alcohol and substance use reduction goals.

Behavioral: ED-SMART intervention

Substance use information

PLACEBO COMPARATOR

The substance use information condition will receive printed health information covering information about substance use (e.g., definitions, hazards, potential for addiction, injury, and other consequences). Staff will also discuss ways to utilize primary care or establish care with a primary care provider to provide ongoing follow-up.

Behavioral: Substance use information

Interventions

The ED-SMART intervention will include: (i) a brief (approximately 15 minutes) counseling session in the emergency department and (ii) five, monthly brief counseling sessions (approximately 15 to 30 minutes) delivered by telehealth. These sessions will focus on creating individualized strategies to help participants reach their alcohol and substance use reduction goals

ED-SMART intervention

The substance use information condition will receive printed health information covering information about substance use (e.g., definitions, hazards, potential for addiction, injury, and other consequences). Research staff will also discuss ways to utilize primary care or establish care with a primary care provider to provide ongoing follow-up.

Substance use information

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult at least 18 years of age
  • Lower or Moderate Risk score on one or more substance use types on National Institute on Drug Abuse (NIDA)-Modified Alcohol, Smoking, and Substance Use Involvement Test (ASSIST). Participants may also endorse alcohol use in conjunction with substance use as indicated by an Alcohol Use Disorder Identification Test-Concise (AUDIT-C) score of Moderate Risk.

You may not qualify if:

  • A priori participant request for participation
  • Concurrently enrolled in other study of substance use disorder prevention
  • Prisoner at time of enrollment
  • Known to be pregnant at time of enrollment
  • Past substance use disorder or substance use treatment
  • High risk score for one or more substances on the NIDA-Modified ASSIST or problematic alcohol use alone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Jennifer L. Brown, PhD

    Purdue University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jennifer L Brown, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 7, 2026

First Posted

April 14, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

September 1, 2029

Study Completion (Estimated)

September 1, 2029

Last Updated

April 14, 2026

Record last verified: 2026-04